Daktarin Oral Gel Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Miconazole

Indications/Uses

Oropharyngeal cavity & GIT candidosis in adults & ped ≥6 mth.

Click to view Daktarin Oral Gel detailed prescribing information

Dosage/Direction for Use

Oropharyngeal candidosis Adult & childn ≥2 yr 2.5 mL qds. Infant 6-24 mth 1.25 mL qds. GIT candidosis Adult, childn & infant ≥6 mth 20 mg/kg daily in 4 divided doses. Max: 250 mg qds.

Click to view Daktarin Oral Gel detailed prescribing information

Overdosage

View Daktarin Oral Gel overdosage for action to be taken in the event of an overdose.

Contraindications

Hypersensitivity miconazole or other imidazole derivatives. Combination w/ substrates prolonging QT interval eg, astemizole, bepridil, cisapride, dofetilide, halofantrine, mizolastine, pimozide, quinidine, sertindole, terfenadine; ergot alkaloids; HMG-CoA reductase inhibitors eg, simvastatin, lovastatin; triazolam, oral midazolam; warfarin. Hepatic dysfunction. Infants <6 mth.

Click to view Daktarin Oral Gel detailed prescribing information

Special Precautions

Discontinue use if severe hypersensitivity & serious skin reaction occur. Hypoglycemia. Concomitant use w/ phenytoin & oral hypoglycemics. Ensure gel does not obstruct the throat especially in infants & young childn 6 mth-2 yr. Avoid use during pregnancy. Lactation.

Click to view Daktarin Oral Gel detailed prescribing information

Use In Pregnancy & Lactation

Click to view Daktarin Oral Gel detailed prescribing information

Adverse Reactions

Dysgeusia; dry mouth, nausea, oral discomfort, vomiting, regurgitation; abnormal taste.

Click to view Daktarin Oral Gel detailed prescribing information

Drug Interactions

Inhibited metabolism of substrates prolonging QT interval eg, astemizole, bepridil, cisapride, dofetilide, halofantrine, mizolastine, pimozide, quinidine, sertindole, terfenafine; ergot alkaloids; HMG-CoA reductase inhibitors eg, simvastatin, lovastatin; triazolam, oral midazolam; warfarin. Increased or prolonged therapeutic outcome &/or adverse effects w/ oral hypoglycemics eg, sulphonylureas; phenytoin; HIV PIs eg, saquinavir; antineoplastic agents eg, vinca alkaloids, busulfan, docetaxel; Ca-channel blockers eg, dihydropyridines, verapamil; immunosuppresive agents eg, cyclosporine, tacrolimus, sirolimus; alfentanil, alprazolam, brotizolam, buspirone, carbamazepine, cilostasol, disopyramide, ebastine, methylprednisolone, midazolam IV, reboxetine, rifabutin, sildenafil, trimetrexate.

Click to view Daktarin Oral Gel detailed prescribing information

Caution For Usage

For caution against possible variation of physical aspect of medicine... Click to view Daktarin Oral Gel detailed prescribing information

Storage

View Daktarin Oral Gel storage conditions for details to ensure optimal shelf-life.

Description

View Daktarin Oral Gel description for details of the chemical structure and excipients (inactive components).

Action

View Daktarin Oral Gel mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Oropharyngeal anti-infectives

ATC Classification

A01AB09 - miconazole ; Belongs to the class of local antiinfective and antiseptic preparations. Used in the treatment of diseases of the mouth.

Regulatory Classification

Presentation/Packing

Form

Daktarin Oral Gel 2%

Packing/Price

15 g x 1's

Daktarin Oral Gel

miconazole

Manufacturer:

JNTL

Distributor:

Zuellig Pharma